ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

X
feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Mice  (6)
  • American Association for the Advancement of Science (AAAS)  (6)
  • American Association for the Advancement of Science
  • American Geophysical Union (AGU)
  • American Institute of Physics
  • Cambridge University Press
  • National Academy of Sciences
  • Nature Publishing Group (NPG)
  • 1980-1984  (6)
  • 1945-1949
Sammlung
Schlagwörter
Verlag/Herausgeber
  • American Association for the Advancement of Science (AAAS)  (6)
  • American Association for the Advancement of Science
  • American Geophysical Union (AGU)
  • American Institute of Physics
  • Cambridge University Press
    • +
Erscheinungszeitraum
Jahr
  • 1
    facet.materialart.
    Unbekannt
    Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro (1982)
    American Association for the Advancement of Science (AAAS)
    Details
    Publikationsdatum: 1982-12-10
    Beschreibung: Rhodamine-123, a cationic laser dye, markedly reduced the clonal growth of carcinoma cells but had little effect on nontumorigenic epithelial cells in vitro. This selective inhibitory effect of Rhodamine-123 on some carcinomas is unusual since known anticancer drugs, such as arabinosyl cytosine and methotrexate, have not been shown to exhibit such selectivity in vitro.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Bernal, S D -- Lampidis, T J -- Summerhayes, I C -- Chen, L B -- New York, N.Y. -- Science. 1982 Dec 10;218(4577):1117-9.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7146897" target="_blank"〉PubMed〈/a〉
    Schlagwort(e): Animals ; Carcinoma/*drug therapy ; Cell Line ; Cell Survival/drug effects ; Mice ; Mitochondria/metabolism ; Neoplasms, Experimental/drug therapy ; Rhodamine 123 ; Rhodamines/metabolism/therapeutic use ; Time Factors ; Urinary Bladder Neoplasms/drug therapy
    Print ISSN: 0036-8075
    Digitale ISSN: 1095-9203
    Thema: Biologie , Chemie und Pharmazie , Informatik , Medizin , Allgemeine Naturwissenschaft , Physik
    Publiziert von American Association for the Advancement of Science (AAAS)
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
    AKTUELLE ARTIKEL
  • 2
    facet.materialart.
    Unbekannt
    Genetically obese mice: resistance to metastasis of B16 melanoma and enhanced T-lymphocyte mitogenic responses (1983)
    American Association for the Advancement of Science (AAAS)
    Details
    Publikationsdatum: 1983-06-10
    Beschreibung: The metastasis of B16 melanoma cells differed significantly in obese (ob/ob) and lean (+/?) female mice of strain C57BL/6J. When the mice were inoculated subcutaneously with melanoma cells at 10 to 11 months of age, the primary tumor grew more slowly in obese than in lean littermates and the frequency of lung metastasis was greatly reduced. When the mice were injected with the cells at 4 to 7 months, the primary tumor grew at the same rate in obese and lean mice, but the obese mice again showed a significantly reduced frequency of lung metastasis. That this effect was related to an enhanced immunocompetence in obese mice was supported by the finding that splenic lymphocytes of ob/ob mice showed three times the proliferative response to the T-cell mitogen concanavalin A compared with the proliferative response of lean control mice. The ob/ob mouse may provide a model for the study of enhanced immunocompetence in obese individuals.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Thompson, C I -- Kreider, J W -- Black, P L -- Schmidt, T J -- Margules, D L -- New York, N.Y. -- Science. 1983 Jun 10;220(4602):1183-5.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6602379" target="_blank"〉PubMed〈/a〉
    Schlagwort(e): Animals ; Female ; Immunity, Innate ; Lung Neoplasms/immunology ; Male ; Melanoma/*immunology ; Mice ; Mice, Inbred C57BL ; *Mice, Obese ; Neoplasm Metastasis ; Neoplasm Transplantation ; Neoplasms, Experimental/immunology ; Rats ; Receptors, Glucocorticoid/physiology ; T-Lymphocytes/*physiology
    Print ISSN: 0036-8075
    Digitale ISSN: 1095-9203
    Thema: Biologie , Chemie und Pharmazie , Informatik , Medizin , Allgemeine Naturwissenschaft , Physik
    Publiziert von American Association for the Advancement of Science (AAAS)
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
    AKTUELLE ARTIKEL
  • 3
    facet.materialart.
    Unbekannt
    Astatine-211--tellurium radiocolloid cures experimental malignant ascites (1981)
    American Association for the Advancement of Science (AAAS)
    Details
    Publikationsdatum: 1981-04-17
    Beschreibung: An investigation of the efficacy of astatine-211--tellurium colloid for the treatment of experimental malignant ascites in mice reveals that this alpha-emitting radiocolloid can be curative without causing undue toxicity to normal tissue. By comparison, negatron-emitting phosphorus-32 as colloidal chromic phosphate had no antineoplastic activity. The most compelling explanation for this striking difference is the dense ionization and short range of action associated with alpha-emission. These results have important implications for the development and use of alpha-emitters as radiocolloid therapy for the treatment of human tumors.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Bloomer, W D -- McLaughlin, W H -- Neirinckx, R D -- Adelstein, S J -- Gordon, P R -- Ruth, T J -- Wolf, A P -- CA-12662/CA/NCI NIH HHS/ -- CA-15523/CA/NCI NIH HHS/ -- NS-15380/NS/NINDS NIH HHS/ -- New York, N.Y. -- Science. 1981 Apr 17;212(4492):340-1.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7209534" target="_blank"〉PubMed〈/a〉
    Schlagwort(e): Alpha Particles ; Animals ; Ascites/*radiotherapy ; Astatine/*therapeutic use ; Cell Survival/radiation effects ; Chromium/therapeutic use ; *Chromium Compounds ; Colloids ; Female ; Mice ; Neoplasm Transplantation ; Neoplasms, Experimental/*radiotherapy ; Ovarian Neoplasms ; Phosphates/therapeutic use ; Phosphorus Radioisotopes/therapeutic use ; Radioisotopes/*therapeutic use ; Tellurium/*therapeutic use ; Transplantation, Homologous
    Print ISSN: 0036-8075
    Digitale ISSN: 1095-9203
    Thema: Biologie , Chemie und Pharmazie , Informatik , Medizin , Allgemeine Naturwissenschaft , Physik
    Publiziert von American Association for the Advancement of Science (AAAS)
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
    AKTUELLE ARTIKEL
  • 4
    facet.materialart.
    Unbekannt
    Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye (1983)
    American Association for the Advancement of Science (AAAS)
    Details
    Publikationsdatum: 1983-10-14
    Beschreibung: Carcinoma cells and normal epithelial cells differ in the mitochondrial retention of a permeant cationic compound, rhodamine 123. The possibility of utilizing this difference in carcinoma chemotherapy was investigated. Rhodamine 123 exhibited anticarcinoma activity in mice, and this activity was potentiated by 2-deoxyglucose.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Bernal, S D -- Lampidis, T J -- McIsaac, R M -- Chen, L B -- CA22427/CA/NCI NIH HHS/ -- CA29793/CA/NCI NIH HHS/ -- CA33847/CA/NCI NIH HHS/ -- New York, N.Y. -- Science. 1983 Oct 14;222(4620):169-72.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6623064" target="_blank"〉PubMed〈/a〉
    Schlagwort(e): Animals ; Carcinoma/*drug therapy ; Carcinoma, Ehrlich Tumor/*drug therapy ; Cell Line ; Deoxyglucose/therapeutic use ; Drug Synergism ; Drug Therapy, Combination ; Energy Metabolism/drug effects ; Mice ; Mitochondria/drug effects ; Rhodamine 123 ; Rhodamines/*therapeutic use ; Urinary Bladder Neoplasms/*drug therapy ; Xanthenes/*therapeutic use
    Print ISSN: 0036-8075
    Digitale ISSN: 1095-9203
    Thema: Biologie , Chemie und Pharmazie , Informatik , Medizin , Allgemeine Naturwissenschaft , Physik
    Publiziert von American Association for the Advancement of Science (AAAS)
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
    AKTUELLE ARTIKEL
  • 5
    facet.materialart.
    Unbekannt
    Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound (1981)
    American Association for the Advancement of Science (AAAS)
    Details
    Publikationsdatum: 1981-08-28
    Beschreibung: Benzoyl peroxide, a widely used free radical-generating compound, promoted both papillomas and carcinomas when it was topically applied to mice after 7,12-dimethylbenz[a]anthracene initiation. Benzoyl peroxide was inactive on the skin as a complete carcinogen or as a tumor initiator. A single topical application of benzoyl peroxide produced a marked epidermal hyperplasia and induced a large number of dark basal keratinocytes, effects similar to those produced by the potent tumor promoter 12-O-tetradecanoyl phorbol-13-acetate. Benzoyl peroxide, like other known tumor promoters, also inhibited metabolic cooperation (intercellular communication) in Chinese hamster cells. In view of these results caution should be recommended in the use of this and other free radical-generating compounds.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Slaga, T J -- Klein-Szanto, A J -- Triplett, L L -- Yotti, L P -- Trosko, K E -- CA 21104/CA/NCI NIH HHS/ -- New York, N.Y. -- Science. 1981 Aug 28;213(4511):1023-5.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6791284" target="_blank"〉PubMed〈/a〉
    Schlagwort(e): 9,10-Dimethyl-1,2-benzanthracene ; Animals ; *Benzoyl Peroxide ; *Cocarcinogenesis ; Free Radicals ; Mice ; Neoplasms, Experimental ; *Peroxides ; Skin Neoplasms/*chemically induced ; Tetradecanoylphorbol Acetate
    Print ISSN: 0036-8075
    Digitale ISSN: 1095-9203
    Thema: Biologie , Chemie und Pharmazie , Informatik , Medizin , Allgemeine Naturwissenschaft , Physik
    Publiziert von American Association for the Advancement of Science (AAAS)
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
    AKTUELLE ARTIKEL
  • 6
    facet.materialart.
    Unbekannt
    Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres (1982)
    American Association for the Advancement of Science (AAAS)
    Details
    Publikationsdatum: 1982-09-10
    Beschreibung: Spheres coated with antibodies specific for myosin were used to detect myocardial cell membrane disruption by scanning electron microscopy. Injury in a population of cultured myocytes as then followed and measured by fluorescence-activated cell sorting. This approach provides a unique method for quantitating the evolution of myocardial injury and potentially for assessing the efficacy of interventions aimed at myocardial protection.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Khaw, B A -- Scott, J -- Fallon, J T -- Cahill, S L -- Haber, E -- Homcy, C -- HL-17665/HL/NHLBI NIH HHS/ -- New York, N.Y. -- Science. 1982 Sep 10;217(4564):1050-3.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7051286" target="_blank"〉PubMed〈/a〉
    Schlagwort(e): Animals ; Cell Membrane/ultrastructure ; Cell Separation ; Coronary Disease/pathology ; Culture Media ; Flow Cytometry ; Fluorescent Antibody Technique ; Glucose/pharmacology ; Mice ; Microscopy, Electron, Scanning ; Myocardium/*pathology ; Myosins/*analysis/immunology
    Print ISSN: 0036-8075
    Digitale ISSN: 1095-9203
    Thema: Biologie , Chemie und Pharmazie , Informatik , Medizin , Allgemeine Naturwissenschaft , Physik
    Publiziert von American Association for the Advancement of Science (AAAS)
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
    AKTUELLE ARTIKEL
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...